“Tralokinumab Treatment In Patients With Atopic Dermatitis and Moderate-to-Severe Hand Involvement: Results From the 32-Week Phase 3b ADHAND Trial”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s744. Accessed April 29, 2026. https://skin.dermsquared.com/skin/article/view/4105.